TLRY
Tilray Inc
NASDAQ: TLRY · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$6.24
+1.63% today
Updated 2026-04-30
Market cap
$784.60M
P/E ratio
—
P/S ratio
0.91x
EPS (TTM)
$-14.63
Dividend yield
—
52W range
$4 – $23
Volume
4.5M
Tilray Inc (TLRY) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-156.70%
Operating margin
-52.70%
ROE
-63.20%
ROA
-1.47%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | — | $-96428.00 | — | — | — |
| 2013 | — | $-41989.00 | — | — | — |
| 2014 | — | $-41989.00 | — | — | — |
| 2015 | $443703.00 | $-5.27M | 144.14% | -615.78% | -1,186.63% |
| 2016 | $6.47M | $305123.00 | 70.87% | -12.93% | 4.72% |
| 2017 | $15.17M | $3.12M | 84.63% | -6.81% | 20.54% |
| 2018 | $28.63M | $22.84M | 110.75% | -33.66% | 79.77% |
| 2019 | $179.30M | $-25.04M | 24.27% | -77.48% | -13.96% |
| 2020 | $405.33M | $-102.54M | 23.70% | -25.66% | -25.30% |
| 2021 | $619.67M | $-443.75M | 24.01% | -25.76% | -71.61% |
| 2022 | $792.12M | $-601.05M | 18.59% | -97.14% | -75.88% |
| 2023 | $844.72M | $-1.96B | 23.43% | -218.41% | -231.64% |
| 2024 | $1.07B | $-333.80M | 28.31% | -22.15% | -31.05% |
| 2025 | $1.13B | $-3.00B | 29.29% | -277.93% | -266.25% |